icon-folder.gif   Conference Reports for NATAP  
 
  18th International Workshop on
Clinical Pharmacology of Antiviral Therapy
June 14-17, 2017
Chicago, Ill.C
Back grey_arrow_rt.gif
 
 
 
Evaluation of the Drug-Drug Interaction (DDI)
Potential Between Cobicistat-Boosted Protease Inhibitors and Statins

 
 
  Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-17, 2017, Chicago
 
Joseph M. Custodio, Steve K. West, Devi SenGupta, Arian Zari, Rita Humeniuk, Kah Hiing J. Ling, Moupali Das, Brian P. Kearney
Gilead Sciences, Inc., Foster City, CA
 
Atazanavir/cobicistat prescribing information:
http://packageinserts.bms.com/pi/pi_evotaz.pdf
 
Darunavir/cobicistat prescribing information:
https://www.prezcobixhcp.com/sites/www.prezcobix.com-hcp/files/prescribing-information-prezcobix.pdf
 
Atazanavir PI Product Insert - NATAP
www.natap.org/2016/HIV/011916_01.htm

EASL1

EASL2

EASL3

EASL4

EASL5